Vault-13

Birchview Capital, LP

BURLINGTON, VT · CIK 1618205 · 13F filing filed 2021-08-10

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$167.2m reported value -0.8% vs Q1 2021
62positions
72.2%in top 10
9 new 5 added 4 reduced 1 sold out vs Q1 2021

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BRISTOL-MYERS SQUIBB CO COM BMY BMY 796,106 $53.2m31.82% 31.82% AddedShares held: Q3 2020 794.4k, Q4 2020 794.4k, Q1 2021 794.2k, Q2 2021 796.1k +1.9k +1,920 0.2%
2 ACCELERATE DIAGNOSTICS INC COM COM 2,232,857 $18.0m10.74% 10.74% AddedShares held: Q3 2020 2.2m, Q4 2020 2.2m, Q1 2021 2.2m, Q2 2021 2.2m +19.5k +19,531 0.9%
3 BIODESIX INC COM COM 1,104,953 $14.6m8.73% 8.73% UnchangedShares held: Q3 2020 0, Q4 2020 1.1m, Q1 2021 1.1m, Q2 2021 1.1m
4 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 80,200 $7.8m4.67% 4.67% UnchangedShares held: Q3 2020 78.0k, Q4 2020 80.2k, Q1 2021 80.2k, Q2 2021 80.2k
5 QUIDEL CORP COM QDEL QDEL 59,684 $7.6m4.57% 4.57% AddedShares held: Q3 2020 58.6k, Q4 2020 58.6k, Q1 2021 58.6k, Q2 2021 59.7k +1.0k +1,040 1.8%
6 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 199,400 $4.9m2.91% 2.91% AddedShares held: Q3 2020 102.0k, Q4 2020 102.0k, Q1 2021 177.0k, Q2 2021 199.4k +22.4k +22,400 12.7%
7 BIOGEN INC COM BIIB BIIB 12,100 $4.2m2.51% 2.51% UnchangedShares held: Q3 2020 11.0k, Q4 2020 12.1k, Q1 2021 12.1k, Q2 2021 12.1k
8 ALBIREO PHARMA INC COM BIOD BIOD 111,000 $3.9m2.34% 2.34% UnchangedShares held: Q3 2020 58.0k, Q4 2020 92.0k, Q1 2021 111.0k, Q2 2021 111.0k
9 FOGHORN THERAPEUTICS INC COM FHTX FHTX 314,143 $3.4m2.01% 2.01% UnchangedShares held: Q3 2020 0, Q4 2020 314.1k, Q1 2021 314.1k, Q2 2021 314.1k
10 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 18,000 $3.2m1.93% 1.93% UnchangedShares held: Q3 2020 18.0k, Q4 2020 18.0k, Q1 2021 18.0k, Q2 2021 18.0k
11 KARYOPHARM THERAPEUTICS INC COM COM 230,000 $2.4m1.42% 1.42% UnchangedShares held: Q3 2020 168.0k, Q4 2020 188.0k, Q1 2021 230.0k, Q2 2021 230.0k
12 BLUEBIRD BIO INC COM COM 74,000 $2.4m1.42% 1.42% ReducedShares held: Q3 2020 60.0k, Q4 2020 62.0k, Q1 2021 75.5k, Q2 2021 74.0k -1.5k -1,500 -2.0%
13 ACCELERON PHARMA INC COM XLRN XLRN 18,672 $2.3m1.40% 1.40% UnchangedShares held: Q3 2020 18.7k, Q4 2020 18.7k, Q1 2021 18.7k, Q2 2021 18.7k
14 MASIMO CORP COM MASI MASI 8,000 $1.9m1.16% 1.16% UnchangedShares held: Q3 2020 8.0k, Q4 2020 8.0k, Q1 2021 8.0k, Q2 2021 8.0k
15 ANGION BIOMEDICA CORP COM COM 60,615 $1.9m1.16% 1.16% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 60.6k, Q2 2021 60.6k
16 VANDA PHARMACEUTICALS INC COM VNDA VNDA 80,000 $1.7m1.03% 1.03% UnchangedShares held: Q3 2020 80.0k, Q4 2020 80.0k, Q1 2021 80.0k, Q2 2021 80.0k
17 HARROW INC COM HROW HROW 180,000 $1.7m1.00% 1.00% UnchangedShares held: Q3 2020 180.0k, Q4 2020 180.0k, Q1 2021 180.0k, Q2 2021 180.0k
18 PROTHENA CORP PLC SHS PRTA PRTA 30,247 $1.6m0.93% 0.93% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 30.2k
19 ARENA PHARMACEUTICALS INC COM NEW ARNA ARNA 22,000 $1.5m0.90% 0.90% UnchangedShares held: Q3 2020 22.0k, Q4 2020 22.0k, Q1 2021 22.0k, Q2 2021 22.0k
20 CONTINENTAL RES INC COM CLR CLR 38,600 $1.5m0.88% 0.88% UnchangedShares held: Q3 2020 38.6k, Q4 2020 38.6k, Q1 2021 38.6k, Q2 2021 38.6k
21 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 300,000 $1.3m0.79% 0.79% UnchangedShares held: Q3 2020 300.0k, Q4 2020 300.0k, Q1 2021 300.0k, Q2 2021 300.0k
22 IMMUNOGEN INC COM IMGN IMGN 190,000 $1.3m0.75% 0.75% UnchangedShares held: Q3 2020 190.0k, Q4 2020 190.0k, Q1 2021 190.0k, Q2 2021 190.0k
23 NEKTAR THERAPEUTICS COM COM 72,000 $1.2m0.74% 0.74% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 92.0k, Q2 2021 72.0k -20.0k -20,000 -21.7%
24 ALKERMES PLC SHS ALKS ALKS 50,000 $1.2m0.73% 0.73% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 35.0k, Q2 2021 50.0k +15.0k +15,000 42.9%
25 CULLINAN THERAPEUTICS INC COM CGEM CGEM 45,114 $1.2m0.70% 0.70% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 60.1k, Q2 2021 45.1k -15.0k -15,000 -24.9%
26 ARVINAS INC COM ARVN ARVN 15,000 $1.2m0.69% 0.69% UnchangedShares held: Q3 2020 15.0k, Q4 2020 15.0k, Q1 2021 15.0k, Q2 2021 15.0k
27 EQUITRANS MIDSTREAM CORP COM ETRN ETRN 133,050 $1.1m0.68% 0.68% UnchangedShares held: Q3 2020 133.1k, Q4 2020 133.1k, Q1 2021 133.1k, Q2 2021 133.1k
28 CORCEPT THERAPEUTICS INC COM CORT CORT 50,000 $1.1m0.66% 0.66% UnchangedShares held: Q3 2020 50.0k, Q4 2020 50.0k, Q1 2021 50.0k, Q2 2021 50.0k
29 OVINTIV INC COM OVV OVV 34,200 $1.1m0.64% 0.64% ReducedShares held: Q3 2020 34.4k, Q4 2020 34.4k, Q1 2021 34.4k, Q2 2021 34.2k -150 -150 -0.4%
30 SOLENO THERAPEUTICS INC COM COM 876,899 $1.0m0.60% 0.60% UnchangedShares held: Q3 2020 826.9k, Q4 2020 826.9k, Q1 2021 876.9k, Q2 2021 876.9k
31 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 10,000 $971.0k0.58% 0.58% UnchangedShares held: Q3 2020 10.0k, Q4 2020 10.0k, Q1 2021 10.0k, Q2 2021 10.0k
32 PROGENITY INC COM COM 270,000 $964.0k0.58% 0.58% UnchangedShares held: Q3 2020 0, Q4 2020 250.0k, Q1 2021 270.0k, Q2 2021 270.0k
33 KALVISTA PHARMACEUTICALS INC COM KALV KALV 40,000 $958.0k0.57% 0.57% UnchangedShares held: Q3 2020 30.0k, Q4 2020 30.0k, Q1 2021 40.0k, Q2 2021 40.0k
34 PROGYNY INC COM PGNY PGNY 15,000 $885.0k0.53% 0.53% UnchangedShares held: Q3 2020 15.0k, Q4 2020 15.0k, Q1 2021 15.0k, Q2 2021 15.0k
35 CONTRAFECT CORP COM CFRX CFRX 200,000 $880.0k0.53% 0.53% UnchangedShares held: Q3 2020 255.7k, Q4 2020 200.0k, Q1 2021 200.0k, Q2 2021 200.0k
36 G1 THERAPEUTICS INC COM GTHX GTHX 40,000 $878.0k0.53% 0.53% UnchangedShares held: Q3 2020 40.0k, Q4 2020 40.0k, Q1 2021 40.0k, Q2 2021 40.0k
37 TRANSLATE BIO INC COM COM 30,000 $826.0k0.49% 0.49% UnchangedShares held: Q3 2020 30.0k, Q4 2020 30.0k, Q1 2021 30.0k, Q2 2021 30.0k
38 INARI MED INC COM NARI NARI 7,000 $653.0k0.39% 0.39% UnchangedShares held: Q3 2020 7.0k, Q4 2020 7.0k, Q1 2021 7.0k, Q2 2021 7.0k
39 TURNING POINT THERAPEUTICS I COM COM 8,000 $624.0k0.37% 0.37% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 8.0k
40 PIONEER NAT RES CO COM PXD PXD 3,800 $618.0k0.37% 0.37% UnchangedShares held: Q3 2020 3.8k, Q4 2020 3.8k, Q1 2021 3.8k, Q2 2021 3.8k
41 TG THERAPEUTICS INC COM TGTX TGTX 15,000 $582.0k0.35% 0.35% UnchangedShares held: Q3 2020 15.0k, Q4 2020 15.0k, Q1 2021 15.0k, Q2 2021 15.0k
42 ASPIRA WOMENS HEALTH INC COM COM 103,104 $579.0k0.35% 0.35% UnchangedShares held: Q3 2020 3.1m, Q4 2020 840.1k, Q1 2021 103.1k, Q2 2021 103.1k
43 APELLIS PHARMACEUTICALS INC COM APLS APLS 8,000 $506.0k0.30% 0.30% UnchangedShares held: Q3 2020 8.0k, Q4 2020 8.0k, Q1 2021 8.0k, Q2 2021 8.0k
44 STOKE THERAPEUTICS INC COM STOK STOK 15,000 $505.0k0.30% 0.30% UnchangedShares held: Q3 2020 20.0k, Q4 2020 20.0k, Q1 2021 15.0k, Q2 2021 15.0k
45 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 10,000 $449.0k0.27% 0.27% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 10.0k, Q2 2021 10.0k
46 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 8,000 $426.0k0.25% 0.25% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 8.0k
47 XENCOR INC COM XNCR XNCR 12,300 $424.0k0.25% 0.25% UnchangedShares held: Q3 2020 12.3k, Q4 2020 12.3k, Q1 2021 12.3k, Q2 2021 12.3k
48 LAIRD SUPERFOOD INC COM STK LSF LSF 14,000 $418.0k0.25% 0.25% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 14.0k, Q2 2021 14.0k
49 CHEMOCENTRYX INC COM CCXI CCXI 30,000 $402.0k0.24% 0.24% UnchangedShares held: Q3 2020 30.0k, Q4 2020 30.0k, Q1 2021 30.0k, Q2 2021 30.0k
50 AKEBIA THERAPEUTICS INC COM AKBA AKBA 100,000 $379.0k0.23% 0.23% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
51 DICERNA PHARMACEUTICALS INC COM DRNA DRNA 10,000 $373.0k0.22% 0.22% UnchangedShares held: Q3 2020 10.0k, Q4 2020 10.0k, Q1 2021 10.0k, Q2 2021 10.0k
52 AMICUS THERAPEUTICS INC COM FOLD FOLD 38,000 $366.0k0.22% 0.22% UnchangedShares held: Q3 2020 38.0k, Q4 2020 38.0k, Q1 2021 38.0k, Q2 2021 38.0k
53 SIENTRA INC COM SIEN SIEN 40,000 $318.0k0.19% 0.19% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 40.0k
54 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 20,000 $316.0k0.19% 0.19% UnchangedShares held: Q3 2020 20.0k, Q4 2020 20.0k, Q1 2021 20.0k, Q2 2021 20.0k
55 ELUTIA INC CL A COM ELUT ELUT 30,000 $288.0k0.17% 0.17% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 30.0k
56 KINIKSA PHARMACEUTICALS LTD COM CL A COM CL A 20,000 $279.0k0.17% 0.17% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 20.0k
57 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 9,000 $246.0k0.15% 0.15% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 9.0k, Q2 2021 9.0k
58 INFLARX NV COM IFRX IFRX 70,000 $208.0k0.12% 0.12% UnchangedShares held: Q3 2020 70.0k, Q4 2020 70.0k, Q1 2021 70.0k, Q2 2021 70.0k
59 CYTOKINETICS INC COM NEW CYTK CYTK 10,000 $198.0k0.12% 0.12% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 10.0k
60 HOOKIPA PHARMA INC COM COM 20,000 $183.0k0.11% 0.11% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 20.0k
61 THERAPEUTICSMD INC COM TXMD TXMD 100,000 $119.0k0.07% 0.07% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 100.0k, Q2 2021 100.0k
62 CONCERT PHARMACEUTICALS INC COM CNCE CNCE 20,000 $84.0k0.05% 0.05% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 20.0k, Q2 2021 20.0k

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
YIELD10 BIOSCIENCE INC 18,952 $238.0k19.0k shares